Mindray Medical International Announces Second Quarter 20...(s defined below in the second quarter 20...)

Date:9/3/2008

s defined below, in the second quarter 2008 was US$40.0 million, a 68.5% increase from US$23.7 million in the second quarter 2007. Non-GAAP operating margins were 27.5% in the second quarter 2008, compared to 32.5% in the second quarter 2007 and 35.2% in first quarter 2008. GAAP operating profit in the second quarter 2008 was US$27.8 million compared to US$21.3 million in the second quarter 2007.

Net Income

Second quarter 2008 non-GAAP net income increased 54.7% year-over-year to US$35.2 million from US$22.8 million in the second quarter 2007. Non-GAAP net margins were 24.2% in the second quarter 2008, compared to 31.2% in the second quarter 2007 and 31.8% in the first quarter 2008. Second quarter 2008 GAAP net income was US$24.1 million compared to US$20.4 million in the second quarter 2007. Second quarter 2008 income tax expense was US$6.1 million, representing an effective tax rate of 20.2% compared to a 14.4% effective tax rate in the second quarter 2007, or an increase of 78.2% from US$3.4 million in the second quarter 2007.

Second quarter 2008 basic and diluted non-GAAP earnings per share were US$0.33 and US$0.31 respectively. Second quarter 2007 basic and diluted non- GAAP earnings per share were US$0.21 and US$0.20, respectively. Second quarter 2008 GAAP basic and diluted earnings per share were US$0.22 and US$0.21, respectively. Second quarter 2007 GAAP basic and diluted earnings per share were US$0.19 and US$0.18, respectively. Shares used in the computation of diluted earnings per share increased from 112.1million in the second quarter 2007 to 113.8 million in the second quarter 2008 due to issuances of new shares and grants of share options in the past twelve months.

The China Unified Corporate Income Tax Law (the "New Law") became effective on January 1, 2008. The New Law established a single unified 25% income tax rate for most companies with some preferential income tax rates including a 15% income tax rate to be applicable
'/>"/>

SOURCE Mindray Medical International Limited Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related biology technology :

1. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
2. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
3. Mindray Medical International Announces Third Quarter 2007 Results
4. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
5. Mindray Medical International Announces First Quarter 2008 Results
6. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
7. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
8. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
9. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
10. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
11. BioMS Medical announces its intention to renew a normal course issuer bid